Not medical advice
Lilly building a $3.5B retatrutide plant before approval means FDA approval is basically locked in
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
Tap a verdict. It counts right away, no sign-up needed.
Eli Lilly just broke ground on a $3.5 billion plant in Pennsylvania's Lehigh Valley meant to make next-generation injectable obesity drugs, retatrutide included, with operations starting around 2031. Peptide X is reading it as a sure sign: nobody spends billions on a factory for a drug they think might get rejected. The pushback: big pharma builds capacity years ahead as a bet all the time, the plant covers more than one drug, and a 2031 start date says nothing about whether retatrutide specifically gets approved or when. Approval locked in, or reading too much into a groundbreaking ceremony?
Votes and comments are community opinion, not professional advice.
More claims to call
b/retatrutide →- One month on Reta. Eat your protein boysb/retatrutide · Unrated · 3 comments
- Retatrutide is already FDA approved, compounding pharmacies are just laggingb/retatrutide · Unrated · 1 comment
- The trial hype means long-term safety is a done dealb/retatrutide · Unrated · 0 comments
- Retatrutide is already approved — just buy it like Wegovyb/retatrutide · Unrated · 3 comments
Comments (1)
2031 start date. approval could happen years before that or not at all, a plant tells you nothing